Journal of Cystic Fibrosis
Volume 9, Issue 4 , Pages 284-287 , July 2010

Opportunities for quality improvement in cystic fibrosis newborn screening

  • Molly K. Groose

      Affiliations

    • Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53726, United States
    • Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53726, United States
    • Philip Farrell and Molly Groose were supported by the Robert Turrell Professorship in Medical Leadership of the University of Wisconsin.
    • ,
  • Richard Reynolds

      Affiliations

    • Reynolds Management Services, Middleton, WI 53562, United States
    • ,
  • Zhanhai Li

      Affiliations

    • Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53726, United States
    • ,
  • Philip M. Farrell

      Affiliations

    • Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53726, United States
    • Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53726, United States
    • Corresponding Author InformationCorresponding author. 610 Walnut Street, 785 WARF, Madison, WI 53726-2397, United States. Tel.: +1 608 263 9094.
    • Philip Farrell and Molly Groose were supported by the Robert Turrell Professorship in Medical Leadership of the University of Wisconsin.
    • Dr. Farrell also serves as the Cystic Fibrosis Foundation's national facilitator for implementation of cystic fibrosis newborn screening.

Received 21 January 2010 ,Revised 9 April 2010 ,Accepted 19 April 2010.

References 

  1. Grosse SD, Boyle CA, Botkin JR, et al. Newborn screening for cystic fibrosis evaluation of benefits and risk and recommendations for state newborn screening programs. MMWR. 2004;55:1–39
  2. Campbell PW, White TB. Newborn screening for cystic fibrosis: an opportunity to improve care and outcomes. J Pediatr. 2005;147:S2–S5
  3. Comeau AM, Accurso FJ, White TB, et al. Cystic Fibrosis Foundation. Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatr. 2007;119:e495–e518
  4. National Newborn Screening and Genetics Resource Center. http://genes-r-us.uthscsa.edu/.
  5. Rock MJ, Hoffman G, Laessig RH, Kopish G, Listheim T, Farrell PM. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing. J Pediatr. 2005;147:S73–S77
  6. Farrell PM and the Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Improving the health of patients with cystic fibrosis through newborn screening. Adv Pediatr. 2000;47:79–115
  7. McDermott RE, Mikulak RJ, Beauregard MR. The basics of FMEA. Resources Engineering, Inc; 1996;
  8. The Joint Commission. www.jointcommission.org.
  9. O'Leary DS. In: “Reducing medical errors: a review of innovative strategies to improve patient safety.” Before the House Committee on Energy and Commerce Subcommittee on Health; May 8, 2002. 2002;
  10. Clinical Laboratory Standards Institute . Newborn screening guidelines for premature and/or sick newborns; Guideline I/LA31-P. Wayne, PA, CLSI 2009. 2009;
  11. Clinical laboratory standards institute. sweat testing: sample collection and quantitative chloride analysis; Approved Guideline-Third Edition. C34–A3 Wayne, PA, CLSI 2009.
  12. Farrell MH, Kuruvilla P. Assessment of parental understanding by pediatric residents during counseling after newborn genetic screening. Arch Pediatr Adolesc Med. 2008;162:199–204
  13. Wissow LS, Erby LH. Misunderstanding about communication. Arch Pediatr Adolesc Med. 2008;162:280–281
  14. Castellani C, Southern KW, Brownlee K, et al. European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros. 2009;8:153–173

☆ This project was presented by invitation from the European Cystic Fibrosis Society at the 2009 European Cystic Fibrosis Conference in Brest, France on 12 June 2009 and is published as an abstract in J Cystic Fibrosis 2009;8:S9.

PII: S1569-1993(10)00039-1

doi: 10.1016/j.jcf.2010.04.001

Journal of Cystic Fibrosis
Volume 9, Issue 4 , Pages 284-287 , July 2010

Article Tools